ESMO 2021 - Overall survival (OS) results from the phase III MONALEESA-2

Watch Now ESMO 2021 - Overall survival (OS) results from the phase III MONALEESA-2

ESMO 2021 - KEYNOTE-355: Final results phase III study in mTNBC

Watch Now ESMO 2021 - KEYNOTE-355: Final results phase III study in mTNBC

AI SERIES - Panel Discussion: A review of Precision medicine in cancer therapeutics - Hormone sensitive Breast Cancer and AI challenges

Watch Now AI SERIES - Panel Discussion: A review of Precision medicine in cancer therapeutics - Hormone sensitive Breast Cancer and AI challenges

AI SERIES - Panel Discussion: AI assisted drug development and repurposing in Breast Cancer

Watch Now AI SERIES - Panel Discussion:  AI assisted drug development and repurposing in Breast Cancer

AI SERIES - Panel discussion: Personalized vs precision medicine, clinical applicability

Watch Now AI SERIES - Panel discussion: Personalized vs precision medicine, clinical applicability